If you missed the incredible run up in share price that Santarus (NASDAQ:SNTS) has achieved over the past 18 months, now may be the perfect time to ride the next wave up. Santarus has been one of the strongest stocks in the biotech sector this year with a YTD increase over 350%. The dramatic price increase has been driven by several positive catalysts as described below. Despite this stellar performance, a series of events has contributed to a recent sell off, opening the door for investors to buy shares at a deeply discounted price. In this article I will explain why I believe near term indications with both commercial and pipeline products could alone, be worth significantly more...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|